Patricia Weber, Dr.P.H.

Dr. Patricia Weber was a Program Director at the National Cancer Institute's Small Business Innovation Research (SBIR) Development Center for over 16 years.  In her role, she provided oversight throughout the award period and mentored awardees in their technology goals and commercialization strategy. Dr. Weber also played an active role in several initiatives, including the Applicant Assistance Program (AAP) and now the NCI SBIR/STTR Training and Entrepreneurship Program (STEP), NCI Investor Forum, workshops, and targeted funding initiatives. Dr. Weber will continue to play a role in special initiatives within the office as a part-time contractor.
 
Prior to joining the SBIR Development Center, she held various management-level positions in research and development in both San Diego and Western Montana. She was Director of Microbiology and Immunology at a San Diego-based biotech company that focused on the discovery and development of peptide therapeutics. She then moved to western Montana, where she was the Team Leader of Cardiovascular Pharmacology at Ribi ImmunoChem Research (currently GSK) in Hamilton, MT. In addition to managing the preclinical development efforts of an intravenous biological product for the prevention of ischemia/reperfusion injury associated with cardiopulmonary bypass procedures, she also worked on licensing the therapeutic to potential pharmaceutical partners. She joined the International Heart Institute of Montana in 2000, where she managed the Tissue Engineering and Surgical Research Laboratories. Her work involved the preclinical development of cardiovascular devices, including heart valves, bioengineered blood vessels, and novel, stent-based devices.
 
Dr. Weber completed her Masters and Doctorate in Public Health with an emphasis in Biomedical Sciences at the School of Public Health, University of California at Berkeley.